Tower Research Capital LLC TRC Grows Position in MetLife, Inc. (NYSE:MET)
by Jessica Moore · The Cerbat GemTower Research Capital LLC TRC increased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 136.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 48,064 shares of the financial services provider’s stock after purchasing an additional 27,754 shares during the quarter. Tower Research Capital LLC TRC’s holdings in MetLife were worth $3,935,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. CX Institutional increased its position in shares of MetLife by 15.9% in the fourth quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after acquiring an additional 9,337 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. Smartleaf Asset Management LLC raised its position in MetLife by 27.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after purchasing an additional 2,940 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of MetLife by 1.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock worth $63,559,000 after purchasing an additional 12,723 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC purchased a new stake in shares of MetLife in the fourth quarter worth about $259,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Wall Street Analysts Forecast Growth
MET has been the subject of several recent research reports. Cowen reaffirmed a “buy” rating on shares of MetLife in a research report on Friday, March 7th. Wells Fargo & Company cut their price objective on shares of MetLife from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. cut their price target on MetLife from $88.00 to $86.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 2nd. Finally, Barclays lowered their price objective on MetLife from $95.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday, April 11th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $92.46.
MetLife Stock Up 1.1 %
Shares of NYSE:MET opened at $72.49 on Monday. The company’s fifty day moving average is $79.19 and its two-hundred day moving average is $82.13. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The stock has a market capitalization of $49.38 billion, a price-to-earnings ratio of 12.14, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89.
MetLife (NYSE:MET – Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Equities analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- 3 Tickers Leading a Meme Stock Revival
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- What Do S&P 500 Stocks Tell Investors About the Market?
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- What is the Nikkei 225 index?
- AppLovin: Can Record Profits Overcome Market Skepticism?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).